WHO ICTRP trial
A study to evaluate the safety and tolerability of TAK-831 in patients with…
EUCTR2017-001739-38-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-001739-38-GB |
|---|---|
| Public title | A study to evaluate the safety and tolerability of TAK-831 in patients with schizophrenia. |
| Scientific title | A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult Subjects With Schizophrenia |
| Primary sponsor | Takeda Development Centre Europe Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Schizophrenia MedDRA version: 20.0 Level: PT Classification code 10039626 Term: Schizophrenia System Organ Class: 10037175 - Psychiatric disorders ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03] |
| Interventions | Product Name: TAK-831 Pharmaceutical Form: Tablet INN or Proposed INN: TAK-831 Current Sponsor code: TAK-831 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Pharmaceutical form of the placebo: Tablet… |
| Registration date | Sep 8, 2017 |
| Target size | 32 |
| Secondary IDs | TAK-831-2001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: